Additional Information

Description

Gammagard Liquid is an intravenous immunoglobulin (IVIG) preparation containing immunoglobulin G (IgG) derived from human plasma. It is used for the treatment of various immune system deficiencies and autoimmune conditions. The solution is highly purified and provides a concentrated dose of IgG, which is essential for the immune response to infections. Gammagard Liquid is typically administered through an intravenous infusion.

This product is indicated for patients with primary immunodeficiency diseases (PID), such as common variable immunodeficiency (CVID), and for those who experience chronic inflammatory demyelinating polyneuropathy (CIDP). It is also used in the treatment of immune thrombocytopenic purpura (ITP), a condition that leads to low platelet counts.

The administration of Gammagard Liquid is typically done in a healthcare setting where the patient is closely monitored. It is given intravenously at regular intervals, depending on the clinical condition being treated. The infusion process can vary in duration depending on individual patient needs.